Related Experiment Video
Updated: May 7, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Molecular interactions of Bcl-2 and Bcl-xL with mortalin: identification and functional characterization
Nishant Saxena1, Shashank P Katiyar2, Ye Liu1
1*National Institute of Advanced Industrial Science and Technology (AIST), Central 4, 1-1-1 Higashi, Tsukuba Science City 305-8562, Japan.
Abstract:
Bcl-2 family of proteins consists of both pro-apoptotic and anti-apoptotic members that control cellular apoptosis. They predominantly reside in the mitochondria and control the release of apoptotic factors from the mitochondria to the cytosol by regulating its membrane potential and opening the PT (permeability transition) pore. Here we report bioinformatics and biochemical evidence to demonstrate the interaction between Bcl-2 and Bcl-xL with a stress chaperone, mortalin. We demonstrate that such interaction results in the abrogation of mortalin-p53 interaction leading to nuclear translocation and transcriptional reactivation of p53 function that results in an induction of senescence in cancer cells.
Insights
The Bcl-2 family proteins interact with mortalin, disrupting mortalin-p53 binding. This interaction reactivates p53, inducing senescence in cancer cells.
Area of Science:
- Molecular biology
- Cell biology
- Biochemistry
Background:
- The Bcl-2 protein family regulates apoptosis through mitochondrial pathways.
- Mortalin, a stress chaperone, interacts with p53, influencing its function.
- Mitochondrial outer membrane permeabilization is critical for apoptosis.
Purpose of the Study:
- To investigate the interaction between Bcl-2 family proteins and mortalin.
- To elucidate the functional consequences of this interaction on p53.
- To explore the potential of targeting this interaction for cancer therapy.
Main Methods:
- Bioinformatic analysis to predict interactions.
- Biochemical assays to confirm protein interactions.
- Cellular assays to assess p53 localization and transcriptional activity.
- Senescence induction assays in cancer cells.
Main Results:
- Bcl-2 and Bcl-xL directly interact with mortalin.
- This interaction abrogates the mortalin-p53 complex.
- Disruption of mortalin-p53 interaction leads to p53 nuclear translocation.
- Reactivated p53 induces senescence in cancer cells.
Conclusions:
- Bcl-2 and Bcl-xL binding to mortalin disrupts its interaction with p53.
- This mechanism promotes p53 nuclear accumulation and transcriptional activity.
- Targeting the Bcl-2-mortalin interaction may offer a novel strategy for cancer treatment by inducing senescence.
Related Concept Videos
The Intrinsic Apoptotic Pathway
Cellular Injury V: Apoptosis and Autophagy

